These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 11775998)

  • 21. Brazil's AIDS controversy: antiretroviral drugs, breaking patents, and compulsory licensing.
    Marques UR; Guimarães VS; Sternberg C
    Food Drug Law J; 2005; 60(3):471-7. PubMed ID: 16304752
    [No Abstract]   [Full Text] [Related]  

  • 22. Ensuring access to essential medicines: some economic considerations.
    Maskus KE
    Spec Law Dig Health Care Law; 2003 Jul; (291):9-25. PubMed ID: 15206162
    [No Abstract]   [Full Text] [Related]  

  • 23. Global health and university patents.
    Kapczynski A; Crone ET; Merson M
    Science; 2003 Sep; 301(5640):1629. PubMed ID: 14500943
    [No Abstract]   [Full Text] [Related]  

  • 24. TRIPS, patents & HIV/AIDS drugs.
    Satyanarayana K
    Indian J Med Res; 2005 Apr; 121(4):211-4. PubMed ID: 15817937
    [No Abstract]   [Full Text] [Related]  

  • 25. Access to essential drugs.
    Dev World Bioeth; 2001 Nov; 1(2):89-92. PubMed ID: 12870517
    [No Abstract]   [Full Text] [Related]  

  • 26. Annan meets with drug companies on increasing access.
    AIDS Policy Law; 2001 Oct; 16(20):4. PubMed ID: 11692479
    [No Abstract]   [Full Text] [Related]  

  • 27. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?
    Oliveira MA; Bermudez JA; Chaves GC; Velásquez G
    Bull World Health Organ; 2004 Nov; 82(11):815-21. PubMed ID: 15640916
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The evaluation of the HIV/AIDS drug access initiatives in Côte d'Ivoire, Senegal and Uganda: how access to antiretroviral treatment can become feasible in Africa.
    Katzenstein D; Laga M; Moatti JP
    AIDS; 2003 Jul; 17 Suppl 3():S1-4. PubMed ID: 14565603
    [No Abstract]   [Full Text] [Related]  

  • 29. Martin government to reintroduce patent changes.
    Eggertson L
    CMAJ; 2004 Feb; 170(4):456. PubMed ID: 14970083
    [No Abstract]   [Full Text] [Related]  

  • 30. World CAB meets with Gilead.
    Huff B
    GMHC Treat Issues; 2006; 20(4-7):6-8. PubMed ID: 17228449
    [No Abstract]   [Full Text] [Related]  

  • 31. U.S. is lone holdout on drug access vote.
    AIDS Policy Law; 2003 Jan; 18(1):1. PubMed ID: 12569860
    [No Abstract]   [Full Text] [Related]  

  • 32. World Trade Organization debates patent rights for drugs.
    AIDS Policy Law; 2001 Nov; 16(21):2. PubMed ID: 11769182
    [No Abstract]   [Full Text] [Related]  

  • 33. Do patents prevent access to drugs for HIV in developing countries?
    Boelaert M; Lynen L; Van Damme W; Colebunders R
    JAMA; 2002 Feb; 287(7):840-1; author reply 842-3. PubMed ID: 11851568
    [No Abstract]   [Full Text] [Related]  

  • 34. [HIV antiretroviral agents: new threats to accessibility in developing countries].
    Nau JY
    Rev Med Suisse; 2005 Dec; 1(45):2956. PubMed ID: 16425957
    [No Abstract]   [Full Text] [Related]  

  • 35. Brands in peril as Brazil strives to keep AIDS drugs free.
    Butler D
    Nature; 2004 Jun; 429(6991):493. PubMed ID: 15175719
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of India's new patents law 2005: a physician's perspective.
    Lele RD
    J Assoc Physicians India; 2005 Aug; 53():671-5. PubMed ID: 16398073
    [No Abstract]   [Full Text] [Related]  

  • 37. A survey of the syntheses of active pharmaceutical ingredients for antiretroviral drug combinations critical to access in emerging nations.
    Pinheiro Edos S; Antunes OA; Fortunak JM
    Antiviral Res; 2008 Sep; 79(3):143-65. PubMed ID: 18571246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New guidelines increase access to HIV/AIDS medication.
    AORN J; 2002 Sep; 76(3):448. PubMed ID: 12382663
    [No Abstract]   [Full Text] [Related]  

  • 39. World pharmaceutical developments.
    Bale H
    World Hosp Health Serv; 2002; 38(2):1. PubMed ID: 12402745
    [No Abstract]   [Full Text] [Related]  

  • 40. TRIPS: generic irony.
    Howarth GR
    Br J Gen Pract; 2002 Jan; 52(474):57. PubMed ID: 11791819
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.